SCHEMBL30530884

SCHEMBL30530884

CSCc1cc(NC(=O)OC(C)(C)C)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SREBF2 Q12772 1/20 0.45
▸ NOS3 P29474 1/20 0.44
▸ NOS1 P29475 1/20 0.44
▸ NOS2 P35228 1/20 0.44
▸ CYP17A1 P05093 4/20 0.44
▸ ATR Q13535 1/20 0.44
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ ACSS2 Q9NR19 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ AURKA O14965 1/20 0.39
▸ RPS6KB1 P23443 1/20 0.39
▸ PRKCI P41743 1/20 0.39
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ MAPKAPK2 P49137 2/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30955460 0.87 SREBF2 (0.46) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955394 0.86 SREBF2 (0.43) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955393 0.85 SREBF2 (0.42) SREBF2CYP17A1ATRCA12CA1
SCHEMBL23168284 0.85 SREBF2 (0.47) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955414 0.84 ATR (0.49) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955392 0.83 ACHE (0.43) SREBF2CYP17A1ATRACSS2MAPKAPK2
SCHEMBL30955403 0.83 CYP17A1 (0.42) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955402 0.83 ATR (0.42) SREBF2CYP17A1ATRCA12CA1
SCHEMBL6591045 0.81 SREBF2 (0.49) SREBF2CYP17A1ATRCA12CA1
SCHEMBL30955481 0.81 SREBF2 (0.44) SREBF2CYP17A1ATRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024131938-A1 QUINAZOLINE COMPOUND AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2024-06-27 — — WO disclosed
WO-2023143135-A1 QUINAZOLINE DERIVATIVE AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-08-03 — — WO disclosed
Send feedback